US Stock MarketDetailed Quotes
YMAB Y-mAbs Therapeutics
- 8.280
- -0.290-3.38%
Close Dec 20 16:00 ET
- 8.280
- 0.0000.00%
Post 16:20 ET
370.85MMarket Cap-15.33P/E (TTM)
8.500High7.996Low1.14MVolume8.470Open8.570Pre Close9.45MTurnover4.22%Turnover RatioLossP/E (Static)44.79MShares20.90052wk High4.01P/B224.18MFloat Cap6.48052wk Low--Dividend TTM27.07MShs Float55.215Historical High--Div YieldTTM5.88%Amplitude2.700Historical Low8.269Avg Price1Lot Size
Y-mAbs Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -697.09%-10.67M | 106.29%298K | 73.51%-3.48M | 64.13%-27.23M | 7.22%-8.04M | 93.04%-1.34M | 79.51%-4.73M | 47.35%-13.12M | 25.97%-75.92M | 74.42%-8.66M |
| Net income from continuing operations | 9.67%-7M | -46.76%-9.25M | -3.74%-6.63M | 77.58%-21.43M | -185.39%-988K | 71.86%-7.75M | 84.68%-6.3M | 77.23%-6.39M | -72.90%-95.57M | 103.14%1.16M |
| Operating gains losses | -391.36%-1.18M | 172.96%232K | 207.89%492K | -135.20%-1.26M | -635.54%-890K | -79.39%405K | -122.36%-318K | -246.62%-456K | 88.56%3.58M | -110.56%-121K |
| Depreciation and amortization | -27.98%121K | -31.70%153K | -12.64%159K | -12.40%735K | -30.00%161K | -25.66%168K | 19.15%224K | -6.67%182K | 7.29%839K | -20.96%230K |
| Change In working capital | -298.57%-6.8M | 392.89%5.72M | 88.57%-1.35M | -90.28%-19.73M | 29.87%-9.44M | 24.18%3.43M | -170.09%-1.95M | -379.38%-11.76M | -42.38%-10.37M | -306.15%-13.46M |
| -Change in receivables | 7,400.00%18.3M | -4,137.50%-17.63M | 130.24%1.87M | -105.91%-9.92M | -9.15%-3.58M | 111.94%244K | -119.66%-416K | -282.82%-6.17M | 37.51%-4.82M | -632.14%-3.28M |
| -Change in inventory | 45.02%-1.06M | -101.33%-50K | -50.82%-3.38M | 237.56%1.64M | 545.22%2.05M | -448.91%-1.93M | 411.61%3.76M | -2,851.32%-2.24M | 78.41%-1.19M | 36.55%-460K |
| -Change in payables and accrued expense | -2,083.96%-19.92M | 1,860.19%24.45M | -25.37%-2.62M | -211.86%-4.65M | 65.77%-2.18M | -58.20%1M | -247.92%-1.39M | -236.36%-2.09M | -126.82%-1.49M | -769.30%-6.37M |
| -Change in other current assets | -200.51%-4.13M | 73.18%-1.05M | 321.33%2.79M | -136.76%-6.8M | -70.62%-5.73M | 122.08%4.1M | -516.08%-3.91M | 45.13%-1.26M | -863.30%-2.87M | -8.60%-3.36M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -697.09%-10.67M | 106.29%298K | 73.51%-3.48M | 64.13%-27.23M | 7.22%-8.04M | 93.04%-1.34M | 79.51%-4.73M | 47.35%-13.12M | 25.97%-75.92M | 74.42%-8.66M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 979K | 1.76M | 588K | 19.05%100K | 100K | 0 | 0 | 0 | -99.92%84K | 0 |
| Proceeds from stock option exercised by employees | --979K | --1.76M | --588K | 19.05%100K | --100K | --0 | --0 | --0 | -85.74%84K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --979K | --1.76M | --588K | 19.05%100K | --100K | --0 | --0 | --0 | -99.92%84K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -11.49%77.81M | -18.22%75.75M | -25.65%78.64M | -41.75%105.76M | -24.41%86.57M | -34.23%87.91M | -40.90%92.63M | -41.75%105.76M | 58.39%181.56M | -46.91%114.53M |
| Current changes in cash | -623.92%-9.69M | 143.43%2.06M | 77.99%-2.89M | 64.22%-27.13M | 8.37%-7.94M | 93.03%-1.34M | 79.51%-4.73M | 47.28%-13.12M | -213.53%-75.84M | 74.69%-8.66M |
| Effect of exchange rate changes | --2K | -92.86%1K | 111.11%1K | -80.00%7K | 101.94%2K | --0 | -65.85%14K | -116.98%-9K | -72.87%35K | -298.08%-103K |
| End cash Position | -21.31%68.12M | -11.49%77.81M | -18.22%75.75M | -25.65%78.64M | -25.65%78.64M | -24.41%86.57M | -34.23%87.91M | -40.90%92.63M | -41.75%105.76M | -41.75%105.76M |
| Free cash flow | -697.09%-10.67M | 106.29%298K | 73.51%-3.48M | 64.13%-27.23M | 7.22%-8.04M | 93.04%-1.34M | 79.51%-4.73M | 47.35%-13.12M | 26.66%-75.92M | 74.76%-8.66M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data